Droplet Digital PCR as a Molecular Tool for the Detection of the EGFR T790M Mutation in NSCLC Patients with the EGFR Activating Mutations
Almost 50% of NSCLC patients who initially show a successful response to tyrosine kinase inhibitors targeted therapy (TKI therapy) eventually develop acquired EGFR T790M mutation. The T790M secondary mutation can cause resistance to the targeted therapy and disease relapse. Since this mutation can b...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Sciendo
2024-03-01
|
| Seri Bilgileri: | Balkan Journal of Medical Genetics |
| Konular: | |
| Online Erişim: | https://doi.org/10.2478/bjmg-2023-0020 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|